80
54
Growth Score 80 in past quarter
-7 pts
Heat Score 54 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
609399
Yoshindo is a pharmaceutical company.
About the Company
Toward the research and development required for pharmaceuticals in the future, Yoshindo is currently working on multiple biopharmaceutical businesses. One is contract manufacturing of biopharmaceuticals. This led to the start of an advanced approach to biopharmaceuticals that is unusual for a generic manufacturer. In addition, YL Biologics, a
joint venture established with Rupin Limited of India, has succeeded in the global development of biosimilars for the treatment of rheumatoid arthritis, Emblem, and YL Biologics is in charge of manufacturing and sales in Japan.